Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
10520.135
uM
97.22130
40.41170
0.4897 0.4856 4.0427 0.0293
0.9568
3.6895
SUM159PT
TNBC
Basal B
Pevonedistat
NAE1
NAE1
10520.135
uM
0.79624
0.86326
-0.0471 -0.0481 1.1374 0.3389
0.9955
3.6895
SUM159PT
TNBC
Basal B
Chk2 inhibitor II
CHK2
CHK
10520.14
uM
inf
inf
0.9128 0.9128 0.0000 0.0580
0.4027
3.7031
SUM159PT
TNBC
Basal B
TCS 2312
CHK1
CHK
10520.14
uM
0.48877
0.61898
-0.3612 -0.3328 2.1599 0.4285
0.9923
3.7031
SUM159PT
TNBC
Basal B
NSC 663284
CDC25
CDC
10520.14
uM
1.48650
1.72640
-0.7051 -0.5565 5.0000 0.5214
0.9692
3.7031
SUM159PT
TNBC
Basal B
Vinorelbine
TUBB
TUBB
7919.042
uM
0.01028
0.01106
-0.3868 -0.1639 3.8975 0.7505
0.9702
3.7203
SUM159PT
TNBC
Basal B
Cetuximab
EGFR
ErbB
7919.042
uM
inf
4.91520
0.9535 0.7757 0.6890 0.0060
0.8149
3.7203
SUM159PT
TNBC
Basal B
17-AAG
HSP90
HSP90
7919.04
uM
0.04167
0.05119
-0.4725 -0.2657 2.0719 0.7284
0.9791
3.7375
SUM159PT
TNBC
Basal B
Geldanamycin
HSP90
HSP90
7919.04
uM
0.00594
0.00689
-0.2375 -0.2460 2.7121 0.9268
0.9992
3.7375
MCF 10A
NM
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7485.067
uM
5.35070
8.22830
-0.4965 -0.5259 1.6702 0.3809
0.9972
3.7597
MCF 10A
NM
Basal B
Purvalanol A
CDK1
CDK
7485.067
uM
inf
1000.00000
0.8943 0.7817 0.1323 0.0582
0.6910
3.7597
MCF 10A
NM
Basal B
Ispinesib
KSP
Kinesin
7485.067
uM
0.14987
1.80190
-0.4694 -0.8167 0.3894 0.4872
0.9420
3.7597
SUM159PT
TNBC
Basal B
Temsirolimus
MTOR
MTOR
11057.144
uM
3.51290
26.67560
-0.7417 -1.0000 0.5419 0.4064
0.8413
3.7784
SUM159PT
TNBC
Basal B
SB-3CT
MMP2/9
MMP
11057.144
uM
22.69590
50.71310
-0.4344 -1.0000 1.3664 0.1434
0.9948
3.7784
SUM159PT
TNBC
Basal B
JNK-IN-5A
JNK
JNK
11057.144
uM
14.15840
170.79050
-0.1209 -1.0000 0.4412 0.2119
0.8005
3.7784
SUM159PT
TNBC
Basal B
L-779450
BRAF
MAPK
10520.137
uM
18.60730
49.81870
0.2133 -1.0000 1.1155 0.1476
0.8304
3.7823
SUM159PT
TNBC
Basal B
FR180204
ERK1/2
MAPK
10520.137
uM
inf
inf
0.8283 0.8283 0.0000 0.0670
0.5419
3.7823
SUM159PT
TNBC
Basal B
5-FU
TYMS
TYMS
7919.017
uM
68.19810
71.10910
-0.0335 -0.0155 0.7291 0.4298
0.9904
3.7958
SUM159PT
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7919.017
uM
3.87590
6.04680
-0.5573 -0.4798 1.5126 0.4101
0.9928
3.7958
SUM159PT
TNBC
Basal B
Epirubicin
TOP2
TOP
7919.017
uM
0.18887
0.25521
-0.6913 -0.3973 1.9428 0.6797
0.9592
3.7958
SUM159PT
TNBC
Basal B
Bosutinib
Src
nRTK
11057.145
uM
3.35180
5.16640
-0.6605 -0.6816 1.9876 0.4174
0.9853
3.8266
SUM159PT
TNBC
Basal B
Nilotinib
ABL
nRTK
11057.145
uM
inf
inf
1.0062 1.0062 0.0000 -0.0143
-0.1841
3.8266
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
11057.145
uM
0.05731
0.07460
-0.7373 -0.5011 2.6315 0.7726
0.9669
3.8266
SUM159PT
TNBC
Basal B
MG-132
Proteasome
Proteasome
11057.145
uM
0.05731
0.07460
-0.7373 -0.5011 2.6315 0.7726
0.9669
3.8266
SUM159PT
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
11057.154
uM
8.08130
9.68710
-0.5505 -0.5595 4.1437 0.1410
0.9976
3.8498